A detailed history of Baker Ellis Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 400 shares of LLY stock, worth $327,572. This represents 0.05% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$327,572
Previous $362,000 2.21%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$724.87 - $909.04 $25,370 - $31,816
-35 Reduced 8.05%
400 $362,000
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $20,727 - $27,729
35 Added 8.75%
435 $338,000
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $173,880 - $239,719
400 New
400 $214,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Baker Ellis Asset Management LLC Portfolio

Follow Baker Ellis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Ellis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Ellis Asset Management LLC with notifications on news.